APA (7th ed.) Citation

Lu, Z., Liu, C., Wu, Q., & Deng, Y. (2022). High-coverage targeted lipidomics could reveal lipid alterations and evaluate therapeutic efficacy of membranous nephropathy. Nutrition & Metabolism, 19(1), 1. https://doi.org/10.1186/s12986-022-00701-4

Chicago Style (17th ed.) Citation

Lu, Zhenzhen, Conghui Liu, Qingqing Wu, and Yueyi Deng. "High-coverage Targeted Lipidomics Could Reveal Lipid Alterations and Evaluate Therapeutic Efficacy of Membranous Nephropathy." Nutrition & Metabolism 19, no. 1 (2022): 1. https://doi.org/10.1186/s12986-022-00701-4.

MLA (9th ed.) Citation

Lu, Zhenzhen, et al. "High-coverage Targeted Lipidomics Could Reveal Lipid Alterations and Evaluate Therapeutic Efficacy of Membranous Nephropathy." Nutrition & Metabolism, vol. 19, no. 1, 2022, p. 1, https://doi.org/10.1186/s12986-022-00701-4.